Immediate prostaglandin E2 synthesis in rat 3Y1 fibroblasts following vasopressin V1a receptor stimulation

Biochemical and Biophysical Research Communications

Volumn 354, Issue 3, 2007, Pages 676-680

  Nakatani, Yoshihito ^a   Chin, Yuka ^a   Hara, Shuntaro ^a   Kudo, Ichiro ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Cytosolic phospholipase A2 ; Mitogen activated protein kinase; Phosphatidylinositol 3 kinase; Prostaglandin E2; V1a receptor; Vasopressin

Indexed keywords

CYCLOOXYGENASE 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHOLIPASE A2; PROSTAGLANDIN E2; VASOPRESSIN V1A RECEPTOR; ARGIPRESSIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE A; PHOSPHOLIPASE A2 ALPHA; PHOSPHOLIPASE A2-ALPHA; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN KINASE C; UNCLASSIFIED DRUG; VASOCONSTRICTOR AGENT; VASOPRESSIN RECEPTOR;

ANIMAL CELL; ARTICLE; CELL LINE; CYTOSOL; ENZYME ACTIVATION; ENZYME SYNTHESIS; FIBROBLAST; HORMONE SYNTHESIS; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; METABOLISM;

RATTUS;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ARGININE VASOPRESSIN; CELLS, CULTURED; CYCLOOXYGENASE 1; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; FIBROBLASTS; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOLIPASES A; PROTEIN KINASE C; RATS; RECEPTORS, VASOPRESSIN; VASOCONSTRICTOR AGENTS;

EID: 33846589809     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.01.041     Document Type: Article

References (26)

1. Share L. Role of vasopressin in cardiovascular regulation. Physiol. Rev. 68 (1988) 1248-1284
2. Liu J.-P., Engler D., Funder J.W., and Robinson P.J. Evidence that the stimulation by arginine vasopressin of the release of adrenocorticotropin from the ovine anterior pituitary involves the activation of protein kinase C. Mol. Cell. Endocrinol. 87 (1992) 35-47
3. Birnbaumer M., Seibold A., Gilbert S., Ishido M., Barberis C., Antaramian A., Brabet P., and Rosenthal W. Molecular cloning of the receptor for human antidiuretic hormone. Nature 357 (1992) 333-335
4. Thibonnier M., Auzan C., Madhun Z., Wilkins P., Berti-Mattera L., and Clauser E. Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor. J. Biol. Chem. 269 (1994) 3304-3310
5. Thibonnier M. Signal transduction of V1-vascular vasopressin receptors. Regul. Pept. 38 (1992) 1-11
6. 2. J. Biol. Chem. 273 (1998) 14411-14423
7. 2s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways. J. Biol. Chem. 274 (1999) 3103-3115
8. Kobayashi T., Nakatani Y., Tanioka T., Tsujimoto M., Nakajo S., Nakaya K., Murakami M., and Kudo I. Regulation of cytosolic prostaglandin E synthase by phosphorylation. Biochem. J. 381 (2004) 59-69
9. 2 generation in rat 3Y1 fibroblasts. J. Biol. Chem. 273 (1998) 1733-1740
10. 2 synthesis in fibroblasts. Eur. J. Pharmacol. 485 (2004) 53-59
11. Yang Y., Huang W., and Lu X. Early changes of endothelin, nitric oxide and arginine-vasopressin in patients with acute cerebral injury. Chin. J. Traumatol. 5 (2002) 259-262
12. Patchev V.K., Mastorakos G., Brady L.S., Redwine J., Wilder R.L., and Chrousos G.P. Increased arginine vasopressin secretion may participate in the enhanced susceptibility of Lewis rats to inflammatory disease. Neuroendocrinology 58 (1993) 106-110
13. Smith R.S., Smith T.J., Blieden T.M., and Phipps R.P. Fibroblasts as sentinel cells; synthesis of chemokines and regulation of inflammation. Am. J. Pathol. 151 (1997) 317-322
14. 2. J. Biol. Chem. 275 (2000) 1161-1168
15. Cotte N., Balestre M.-N., Aumelas A., Mahé E., Phalipou S., Morin D., Hibert M., Manning M., Durroux T., Barberis C., and Mouillac B. Conserved aromatic residues in the transmembrane region VI of the V1a vasopressin receptor differentiate agonist vs. antagonist ligand binding Eur. J. Biochem. 267 (2000) 4253-4263
16. Niermann H., Amiry-Moghaddam M., Holthoff K., Witte O.W., and Petter Ottersen O. A novel role of vasopressin in the brain: Modulation of activity-dependent water flux in the neocortex. J. Neurosci. 21 (2001) 3045-3051
17. Ervin M.G., Ross M.G., Leake R.D., and Fisher D.A. V1- and V2-receptor contributions to ovine fetal renal and cardiovascular responses to vasopressin. Am. J. Physiol. 262 (1992) R636-R643
18. 2 by MNK1-related protein kinases. J. Biol. Chem. 275 (2000) 37542-37551
19. Nishioka N., Hirai S., Mizuno K., Osada S., Suzuki A., Kosaka K., and Ohno S. Wortmannin inhibits the activation of MAP kinase following vasopressin V1 receptor stimulation. FEBS Lett. 377 (1995) 393-398
20. Jarvi W.D., Turner A.J., Povirk L.F., Traylor R.S., and Grant S. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C. Cancer Res. 54 (1994) 1707-1714
21. 2 from cytosol to the nuclear envelope in rat basophilic leukemia cells stimulated with calcium ionophore or IgE/antigen. J Biol Chem. 270 (1995) 15359-15367
22. 2 is phosphorylated and activated by MAP kinase. Cell 72 (1993) 269-278
23. 2. FEBS Lett. 580 (2006) 4114-4120
24. 2+ and the protein kinase C-dependent activation of p42 mitogen-activated protein kinase. Endocrinology 140 (2006) 1639-1648
25. Ohno S., Mizuno K., Adachi Y., Hata A., Akita Y., Akimoto K., Osada S., Hirai S., and Suzuki K. Activation of novel protein kinases Cδ and Cε upon mitogenic stimulation of quiescent rat 3Y1 fibroblasts. J. Biol. Chem. 269 (1994) 17495-17501
26. 2 and adenylyl cyclase by phorbol ester in RAW264.7 macrophages. Br. J. Pharmacol. 125 (1998) 1601-1609